JP2014520849A5 - - Google Patents

Download PDF

Info

Publication number
JP2014520849A5
JP2014520849A5 JP2014520238A JP2014520238A JP2014520849A5 JP 2014520849 A5 JP2014520849 A5 JP 2014520849A5 JP 2014520238 A JP2014520238 A JP 2014520238A JP 2014520238 A JP2014520238 A JP 2014520238A JP 2014520849 A5 JP2014520849 A5 JP 2014520849A5
Authority
JP
Japan
Prior art keywords
metal
group
bisphosphonate
nanoparticles according
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014520238A
Other languages
English (en)
Japanese (ja)
Other versions
JP6049712B2 (ja
JP2014520849A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/045954 external-priority patent/WO2013009701A2/en
Publication of JP2014520849A publication Critical patent/JP2014520849A/ja
Publication of JP2014520849A5 publication Critical patent/JP2014520849A5/ja
Application granted granted Critical
Publication of JP6049712B2 publication Critical patent/JP6049712B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014520238A 2011-07-08 2012-07-09 抗癌治療及び画像化並びに骨障害治療のための金属ビスホスホネートナノ粒子 Active JP6049712B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161505806P 2011-07-08 2011-07-08
US61/505,806 2011-07-08
PCT/US2012/045954 WO2013009701A2 (en) 2011-07-08 2012-07-09 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders

Publications (3)

Publication Number Publication Date
JP2014520849A JP2014520849A (ja) 2014-08-25
JP2014520849A5 true JP2014520849A5 (enExample) 2015-08-27
JP6049712B2 JP6049712B2 (ja) 2016-12-21

Family

ID=47506842

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014520238A Active JP6049712B2 (ja) 2011-07-08 2012-07-09 抗癌治療及び画像化並びに骨障害治療のための金属ビスホスホネートナノ粒子

Country Status (4)

Country Link
US (3) US9693957B2 (enExample)
EP (2) EP3494974B1 (enExample)
JP (1) JP6049712B2 (enExample)
WO (1) WO2013009701A2 (enExample)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2525780B1 (en) 2010-01-19 2022-09-07 Northwestern University Synthetic nanostructures including nucleic acids and/or other entities
EP3494974B1 (en) 2011-07-08 2023-10-18 The University of North Carolina at Chapel Hill Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
HK1166436A2 (en) * 2011-09-08 2012-10-26 Ybs Graphene Company Limited A method of forming a negative ion emitting product and a product formed by such method
CA2919268C (en) 2013-07-25 2023-09-05 Exicure, Inc. Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
CN105873569B (zh) * 2013-11-06 2020-07-28 芝加哥大学 用于化疗剂、核酸和光敏剂的递送或共递送的纳米级载体
WO2015126502A2 (en) 2013-12-03 2015-08-27 Northwestern University Liposomal particles, methods of making same and uses thereof
WO2015149068A1 (en) 2014-03-28 2015-10-01 The University Of Chicago Chiral ligand-based metal-organic frameworks for broad-scope asymmetric catalysis
WO2015149072A1 (en) 2014-03-28 2015-10-01 The University Of Chicago Metal-organic frameworks containing nitrogen-donor ligands for efficient catalytic organic transformations
US10413565B2 (en) 2014-04-30 2019-09-17 Northwestern University Nanostructures for modulating intercellular communication and uses thereof
AU2015269412B2 (en) * 2014-06-04 2020-03-12 Exicure Operating Company Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
US20160228573A1 (en) * 2014-08-14 2016-08-11 L.E.A.F. Holdings Group Llc Liposome encapsulated affinity drug
US10588564B2 (en) 2014-09-30 2020-03-17 Moein Health, LLC Method and kit for diagnosing and treating neoplastic tissue
BR112017007012A2 (pt) 2014-10-06 2018-03-06 Exicure Inc compostos anti-tnf
US10206871B2 (en) 2014-10-14 2019-02-19 The University Of Chicago Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof
US10806694B2 (en) 2014-10-14 2020-10-20 The University Of Chicago Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
US10517924B2 (en) 2014-11-24 2019-12-31 Northwestern University High density lipoprotein nanoparticles for inflammation
AU2016252864B2 (en) 2015-04-24 2021-10-14 Duke University Metal complexes with bisphosphonate or pyrophosphate useful as imaging agents
JP6415715B2 (ja) 2015-09-30 2018-10-31 デューク・ユニヴァーシティ アスコルベート製剤及び造影剤としての使用方法
RU2657833C2 (ru) * 2015-12-01 2018-06-15 Общество С Ограниченной Ответственностью "Остерос Биомедика" Стабилизированная лекарственная форма конъюгата этидроната с цитарабином и её применение
WO2017120504A1 (en) * 2016-01-08 2017-07-13 Durfee Paul N Osteotropic nanoparticles for prevention or treatment of bone metastases
WO2017174969A1 (en) * 2016-04-08 2017-10-12 The University Of Birmingham Novel nanonization
AU2016403775B2 (en) * 2016-04-22 2021-10-14 Duke University Manganese complexes with substituted bisphosphonates useful as imaging and therapeutic agents
CN109310702A (zh) 2016-05-20 2019-02-05 芝加哥大学 用于化学疗法、靶向疗法、光动力疗法、免疫疗法和它们的任何组合的纳米颗粒
EA030671B1 (ru) 2016-07-20 2018-09-28 Общество С Ограниченной Ответственностью "Остерос Биомедика" Препарат для лечения костных поражений, вызванных злокачественными новообразованиями
CN108203448B (zh) * 2016-12-19 2020-12-15 香港中文大学 促进矿化并提供生物活性离子的持续释放的可注射水凝胶
WO2018201090A1 (en) 2017-04-28 2018-11-01 Exicure, Inc. Synthesis of spherical nucleic acids using lipophilic moieties
JP2020526558A (ja) 2017-07-13 2020-08-31 ノースウェスタン ユニバーシティ オリゴヌクレオチド官能化金属有機構造体ナノ粒子を調製するための一般的かつ直接的な方法
WO2019028250A1 (en) 2017-08-02 2019-02-07 The University Of Chicago NOMOGENEOUS ORGANOMETALLIC ORGANOMETRIC ORGANOMETRIC LAYERS FOR X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, RODIODYNAMIC THERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF
US20190314324A1 (en) * 2018-04-13 2019-10-17 The University Of Chicago Combination of micheliolide derivatives or nanoparticles with ionizing radiation and checkpoint inhibitors for cancer therapy
US12252708B2 (en) 2018-09-24 2025-03-18 Unm Rainforest Innovations Living mammalian cells modified with functional modular nanoparticles
WO2020081581A1 (en) * 2018-10-16 2020-04-23 The Regents Of The University Of Colorado, A Body Corporate Chemiluminescent and fluorescent nanoparticle for optical imaging of cancer
WO2020176716A1 (en) 2019-02-28 2020-09-03 Brinker C Jeffrey Modular metal–organic polyhedra superassembly compositions
US12702719B2 (en) 2019-03-06 2026-08-11 Northwestern University Hairpin-like oligonucleotide-conjugated spherical nucleic acid
US12319711B2 (en) 2019-09-20 2025-06-03 Northwestern University Spherical nucleic acids with tailored and active protein coronae
WO2021062204A1 (en) * 2019-09-27 2021-04-01 Greenmark Biomedical Inc. Bisphosphonate loaded starch nanoparticle
US12378560B2 (en) 2019-10-29 2025-08-05 Northwestern University Sequence multiplicity within spherical nucleic acids
US20230001396A1 (en) * 2019-11-14 2023-01-05 Board Of Regents, The University Of Texas System Compositions and methods for controlled delivery and protection of therapeutic agents
CN111420071A (zh) * 2020-03-27 2020-07-17 苏州欣影生物医药技术有限公司 一种纳米颗粒磁共振造影剂、制备方法及应用
DE102020116859A1 (de) 2020-06-26 2021-12-30 Pharma Development Holding Gmbh Liposomen
IT202000021292A1 (it) * 2020-09-09 2022-03-09 Consiglio Nazionale Ricerche Composizione in forma di polvere a base di microparticelle incorporanti nanoparticelle per la veicolazione di composti terapeutici/diagnostici
KR102514126B1 (ko) * 2020-12-24 2023-03-24 가톨릭대학교 산학협력단 히알루론산 나노입자를 유효성분으로 함유하는 전이성 골종양 광역학 치료용 조성물
EP4304640A1 (en) 2021-03-12 2024-01-17 Northwestern University Antiviral vaccines using spherical nucleic acids
CN114230610B (zh) * 2021-11-26 2023-05-23 西南医科大学附属医院 放射性标记物、其前体化合物、及制法和应用
WO2023107920A1 (en) * 2021-12-07 2023-06-15 The Trustees Of The University Of Pennsylvania Anisamide-containing lipids and compositions and methods of use thereof
CN115501202B (zh) * 2022-10-12 2023-05-19 北京大学 一种递送过渡态唾液酸转移酶抑制剂的核壳纳米粒子及其制备方法和应用
WO2024236527A1 (en) * 2023-05-16 2024-11-21 Magvitae Innovations Inc A novel non-stoichiometric multi-element adjuvant (nsma) and composition thereof
IT202300015396A1 (it) * 2023-07-21 2025-01-21 Torino Politecnico Nanoparticelle rivestite e loro uso per il trasporto di agenti terapeutici e diagnostici
WO2025077898A1 (en) * 2023-10-13 2025-04-17 The Chinese University Of Hong Kong A therapeutic nucleic acid-encased nanoworm for gene delivery and endosomal escape
CN120284914A (zh) * 2025-05-08 2025-07-11 北京大学 双膦酸锰纳米粒及其制备方法和应用

Family Cites Families (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61351A (en) 1980-10-27 1983-12-30 Yeda Res & Dev Organometallic polymers,their preparation and compositions of co-ordination compounds containing them
US5147806A (en) 1988-04-29 1992-09-15 Igen, Inc. Method and apparatus for conducting electrochemiluminescence measurements
US5213788A (en) 1988-09-29 1993-05-25 Ranney David F Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
ES2084825T3 (es) 1990-07-26 1996-05-16 Monsanto Co Procedimiento de preparacion de poliamidas entrecruzadas.
US6013638A (en) 1991-10-02 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
US5858784A (en) 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
US5871710A (en) 1992-09-04 1999-02-16 The General Hospital Corporation Graft co-polymer adducts of platinum (II) compounds
US5591730A (en) * 1993-10-12 1997-01-07 The Regents Of The University Of California Inhibition of urinary calculi growth
US20010003647A1 (en) 1995-06-07 2001-06-14 Ji Sun Coreatant-including electrochemiluminescent compounds, methods, systems and kits utilizing same
US5641623A (en) 1995-01-04 1997-06-24 Martin; Mark T. Electrochemiluminescence assay
US6022737A (en) 1995-11-02 2000-02-08 Amgen Inc. Formulations for non-viral in vivo transfection in the lungs
US5648508A (en) 1995-11-22 1997-07-15 Nalco Chemical Company Crystalline metal-organic microporous materials
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
KR100483256B1 (ko) 1997-01-24 2005-04-15 콘파마 아에스 젬시타빈 유도체
US6180082B1 (en) 1997-11-24 2001-01-30 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method to enhance tissue accumulation of radiolabeled compounds
US6984400B2 (en) 1998-07-14 2006-01-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treating restenosis using bisphosphonate nanoparticles
US6818227B1 (en) 1999-02-08 2004-11-16 Alza Corporation Liposome composition and method for administration of a radiosensitizer
EP1161226B1 (en) 1999-02-18 2004-05-26 SuperGen, Inc. Phosphocholine linked prodrug derivatives
US20020064520A1 (en) 1999-08-19 2002-05-30 Yanina Rozenberg Targeted artificial gene delivery
WO2001022972A2 (en) 1999-09-25 2001-04-05 University Of Iowa Research Foundation Immunostimulatory nucleic acids
US6602932B2 (en) 1999-12-15 2003-08-05 North Carolina State University Nanoparticle composites and nanocapsules for guest encapsulation and methods for synthesizing same
WO2001076577A2 (en) * 2000-04-07 2001-10-18 The Board Of Regents Of The University Of Texas System Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced gi toxicity
US6471968B1 (en) 2000-05-12 2002-10-29 Regents Of The University Of Michigan Multifunctional nanodevice platform
US6548264B1 (en) 2000-05-17 2003-04-15 University Of Florida Coated nanoparticles
US6565873B1 (en) 2000-10-25 2003-05-20 Salvona Llc Biodegradable bioadhesive controlled release system of nano-particles for oral care products
US7374911B2 (en) 2000-12-21 2008-05-20 Labow Mark A Interleukin-1 related gene and protein
US20020127224A1 (en) 2001-03-02 2002-09-12 James Chen Use of photoluminescent nanoparticles for photodynamic therapy
ES2269761T3 (es) 2001-04-30 2007-04-01 The Regents Of The University Of Michigan Estructuras organometalicas isorreticulares, procedimiento para su formacion, y diseño sistematico del calibre de poros y funcionalidad de los mismos, con aplicacion para el almacenamiento de gases.
AU2003226082A1 (en) 2002-03-25 2003-11-11 The General Hospital Corporation Methods of adjuvant photodynamic therapy to enhance radiation sensitization
CA2500311A1 (en) * 2002-09-28 2004-04-08 Mcneil-Ppc, Inc. Modified release dosage forms
EP1542662A1 (en) 2002-09-28 2005-06-22 McNEIL-PPC, INC. Immediate release dosage form comprising shell having openings therein
WO2004041203A2 (en) 2002-11-04 2004-05-21 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
KR100401335B1 (en) 2003-03-08 2003-10-10 Mijitech Co Ltd Metal nanoparticle surface-coated with silicon oxides and preparation thereof
US6878838B2 (en) * 2003-03-24 2005-04-12 The University Of North Carolina At Chapel Hill Chiral porous metal phosphonates for heterogeneous asymmetric catalysis
CA2518223A1 (en) 2003-03-26 2004-10-07 Ltt Bio-Pharma Co., Ltd. Intravenous nanoparticles for targeting drug delivery and sustained drug release
WO2004089345A1 (en) * 2003-04-03 2004-10-21 Semafore Pharmaceuticals Inc. Bone targeting of biodegradable drug-containing nanoparticles
KR101186764B1 (ko) 2003-05-09 2012-09-28 더 리젠츠 오브 더 유니버시티 오브 미시간 결정들에서 우수한 수준의 표면적과 다공성의 성취를 위한 방법의 이행
WO2005000858A2 (en) * 2003-06-27 2005-01-06 Akira Odani Bisphosphonate complexes
CA2533128A1 (en) 2003-07-31 2005-02-10 3M Innovative Properties Company Bioactive compositions comprising triazines
EP1670512A2 (en) 2003-09-23 2006-06-21 Light Sciences Corporation Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted pdt agents
US20050227929A1 (en) 2003-11-13 2005-10-13 Masferrer Jaime L Combination therapy comprising a Cox-2 inhibitor and an antineoplastic agent
US20050147963A1 (en) 2003-12-29 2005-07-07 Intel Corporation Composite organic-inorganic nanoparticles and methods for use thereof
WO2005092195A1 (ja) 2004-03-29 2005-10-06 National Institute Of Radiological Sciences ヒール効果補正フィルタ、ｘ線照射装置、ｘ線ｃｔ装置及びｘ線ｃｔ撮像方法
US20070259966A1 (en) 2004-04-22 2007-11-08 Allos Therapeutics, Inc. Coadministration of Radiation, Efaproxiral Sodium, and Supplemental Oxygen for the Treatment of Cancer
FR2869803B1 (fr) 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
FR2874016B1 (fr) 2004-06-30 2006-11-24 Centre Nat Rech Scient Cnrse Nanoparticules de derives de la gemcitabine
US7964571B2 (en) 2004-12-09 2011-06-21 Egen, Inc. Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
US20070218049A1 (en) 2006-02-02 2007-09-20 Wei Chen Nanoparticle based photodynamic therapy and methods of making and using same
EP1865935B1 (en) * 2005-02-17 2011-06-08 Hadasit Medical Research Services and Development Ltd. Bisphosphonates for treating endometriosis
CN1305937C (zh) 2005-02-25 2007-03-21 复旦大学 一种金属配位聚合物纳米结构材料的制备方法
WO2006102117A1 (en) * 2005-03-17 2006-09-28 Elan Pharma International Limited Nanoparticulate biphosphonate compositions
NO322682B1 (no) 2005-03-18 2006-11-27 Clavis Pharma Asa Anvendelse av gemcitabinderivater for fremstilling av orale doseringsformer ved kreftbehandling, samt slike orale doseringsformer
PE20070360A1 (es) 2005-09-01 2007-04-19 Novartis Ag Composiciones de liposomas
US20080095699A1 (en) 2006-10-20 2008-04-24 Shiying Zheng Imaging contrast agents using nanoparticles
US7263170B2 (en) 2005-09-30 2007-08-28 Pellegrino Anthony J Radiation therapy system featuring rotatable filter assembly
US20070088161A1 (en) * 2005-10-19 2007-04-19 Stockel Richard F Novel chelated bisphosphonates for use as pharmaceutical agents
CA2641785C (en) 2006-02-09 2016-05-31 Simon Fraser University Birefringent metal-containing coordination polymers
US20100189222A1 (en) 2006-02-16 2010-07-29 Steller Micro Devices Panoramic irradiation system using flat panel x-ray sources
KR100943923B1 (ko) 2006-03-17 2010-02-24 홍순해 킬레이팅 유기 고분자와 생물학적 금속으로 이루어진 나노입자, 그리고 ｅｐｒ 효과를 이용한 새로운 광범위 무독성항암제 및 그 제조 방법
US20090317335A1 (en) 2006-04-20 2009-12-24 Wenbin Lin Hybrid Nanomaterials as Multimodal Imaging Contrast Agents
GB0613362D0 (en) 2006-07-05 2006-08-16 Hemocorm Ltd Therapeutic delivery of carbon monoxide
WO2008010263A1 (fr) 2006-07-18 2008-01-24 Mitsubishi Electric Corporation Procédé de production d'une électrode pour le traitement de surface par décharge et procédé de traitement de surface par décharge
US7699099B2 (en) * 2006-08-02 2010-04-20 B.J. Services Company, U.S.A. Modified Christmas tree components and associated methods for using coiled tubing in a well
WO2008016172A1 (fr) * 2006-08-04 2008-02-07 Kurume University Inhibiteur de métastase
US7985868B1 (en) 2006-11-01 2011-07-26 Sandia Corporation Hybrid metal organic scintillator materials system and particle detector
US20080124281A1 (en) 2006-11-29 2008-05-29 Board Of Regents, The University Of Texas System Nanotubular probes as ultrasensitive mr contrast agent
FR2910009B1 (fr) 2006-12-19 2009-03-06 Commissariat Energie Atomique Procede de preparation d'un film organique a la surface d'un support solide dans des conditions non-electrochimiques, su pport solide ainsi obtenu et kit de preparation
WO2008102632A1 (ja) 2007-02-21 2008-08-28 Konica Minolta Medical & Graphic, Inc. Ｘ線バンドパスフィルタ、ｘ線照射システム及びｘ線撮影システム
US20090074828A1 (en) 2007-04-04 2009-03-19 Massachusetts Institute Of Technology Poly(amino acid) targeting moieties
KR20090001013A (ko) 2007-06-29 2009-01-08 주식회사 웰스킨 인돌-3-알킬카복실산을 함유하는 여드름 치료제 및 피지분비 억제제, 및 이를 포함하는 광역학적 치료용 키트
WO2009008345A1 (ja) * 2007-07-06 2009-01-15 Tmrc Co., Ltd. 金属錯体化合物、これを有効成分とする癌治療剤組成物および該金属錯体化合物用の中間体
US8486452B2 (en) 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
WO2009042802A1 (en) 2007-09-25 2009-04-02 The Regents Of The University Of California Edible and biocompatible metal-organic frameworks
FR2921838A1 (fr) * 2007-10-05 2009-04-10 Guerbet Sa Nouveau procede de preparation de nanoparticules recouvertes d'une couche stabilisatrice gem-bisphosphonate couplee a des ligands de biodistribution hydrophile
WO2009139939A2 (en) * 2008-02-22 2009-11-19 The University Of North Carolina At Chapel Hill Hybrid nanoparticles as anti-cancer therapeutic agents and dual therapeutic/imaging contrast agents
US20110053862A1 (en) 2008-03-12 2011-03-03 Intradigm Corporation Compositions comprising survivin sirna and methods of use thereof
GB0807862D0 (en) 2008-04-29 2008-06-04 Uni I Oslo Compounds
US8968705B2 (en) 2008-08-22 2015-03-03 Colorado School Of Mines Gold/lanthanide nanoparticle conjugates and uses thereof
JP5964589B2 (ja) 2008-12-03 2016-08-03 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃアゴニストの製剤およびその使用方法
EP2198885B1 (en) 2008-12-19 2012-02-08 Biolitec AG Calcium phosphate nanoparticles as dye carrier for photodynamic therapy
US9302003B2 (en) 2009-04-24 2016-04-05 Socpra—Sciences Santé´Et Humaines Compositions comprising a radiosensitizer and an anti-cancer agent and methods of uses thereof
AU2010252280A1 (en) 2009-05-25 2012-01-19 Merck Patent Gmbh Continuous administration of cilengitide in cancer treatments
EP2438076B1 (en) * 2009-06-05 2018-12-19 Nanyang Technological University Targeted drug delivery to the bone
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions
WO2011049743A1 (en) 2009-10-06 2011-04-28 Stellarray, Inc. Self contained irradiation system using flat panel x-ray sources
CA2776796C (en) 2009-10-16 2018-11-13 University Health Network Porphyrin nanovesicles
RU2012125350A (ru) 2009-11-20 2013-12-27 Клавис Фарма Аса Парентеральные препараты производных гемцитабина
GB201013307D0 (en) 2010-08-09 2010-09-22 Univ St Andrews Anti-microbial metal organic framework
IT1401882B1 (it) * 2010-10-01 2013-08-28 Rosa De Nanoparticelle autoassemblanti per il rilascio di bifosfonati nel trattamento di tumori.
WO2012138419A1 (en) 2011-04-04 2012-10-11 Georgia Tech Research Corporation Mof nanocrystals
NO2694640T3 (enExample) 2011-04-15 2018-03-17
US20120301537A1 (en) 2011-05-23 2012-11-29 Delta-Fly Pharma, Inc. LIPOSOME CONTAINING shRNA MOLECULE TARGETING A THYMIDYLATE SYNTHASE AND USE THEREOF
CN103857384B (zh) 2011-06-06 2017-07-11 大学健康网络 用于合成卟啉‑磷脂结合物的方法
EP2721032A4 (en) 2011-06-16 2014-11-05 Univ South Florida POLYHEDRIC CAGE WITH METAL OPORPHYRENE EQUIPMENT, METHOD FOR THE PRODUCTION THEREOF AND METHOD FOR THEIR USE
EP3494974B1 (en) 2011-07-08 2023-10-18 The University of North Carolina at Chapel Hill Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
US9517277B2 (en) 2011-07-15 2016-12-13 University Of Georgia Research Foundation, Inc. Immune-stimulating photoactive hybrid nanoparticles
ES2856698T3 (es) 2011-08-23 2021-09-28 Yeda Res & Dev Fotosensibilizadores de (bacterio)clorofila para el tratamiento de enfermedades y trastornos oculares
CN102432654A (zh) 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
WO2013068965A2 (en) 2011-11-11 2013-05-16 Koninklijke Philips Electronics N.V. Lighting apparatus and manufacturing method for manufacturing the lighting apparatus
JP6042450B2 (ja) 2011-12-16 2016-12-14 ナノビオティックスＮａｎｏｂｉｏｔｉｘ 金属材料および酸化ハフニウム材料を含むナノ粒子、その製造および使用
US20130209755A1 (en) 2012-02-15 2013-08-15 Phillip Dene Hustad Self-assembled structures, method of manufacture thereof and articles comprising the same
JP6427097B2 (ja) 2012-06-15 2018-11-21 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． 癌を処置するための組成物および該組成物を製造するための方法
DK2944323T3 (en) 2013-01-11 2019-04-15 Dingfu Biotarget Co Ltd Means for the treatment of tumors, their use and their method
US10350275B2 (en) 2013-09-21 2019-07-16 Advantagene, Inc. Methods of cytotoxic gene therapy to treat tumors
CN105873569B (zh) 2013-11-06 2020-07-28 芝加哥大学 用于化疗剂、核酸和光敏剂的递送或共递送的纳米级载体
WO2015149072A1 (en) 2014-03-28 2015-10-01 The University Of Chicago Metal-organic frameworks containing nitrogen-donor ligands for efficient catalytic organic transformations
WO2015149068A1 (en) 2014-03-28 2015-10-01 The University Of Chicago Chiral ligand-based metal-organic frameworks for broad-scope asymmetric catalysis
US10806694B2 (en) 2014-10-14 2020-10-20 The University Of Chicago Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
US10206871B2 (en) 2014-10-14 2019-02-19 The University Of Chicago Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof
WO2017023667A1 (en) 2015-07-31 2017-02-09 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Immunostimulatory nanocarrier
WO2017066328A1 (en) 2015-10-12 2017-04-20 The University Of Chicago Stabilization of active metal catalysts at metal-organic framework nodes for highly efficient organic transformations
CN105457038A (zh) 2015-11-09 2016-04-06 东南大学 一种速释型药物磷脂化合物及其药物组合物
CN109310702A (zh) 2016-05-20 2019-02-05 芝加哥大学 用于化学疗法、靶向疗法、光动力疗法、免疫疗法和它们的任何组合的纳米颗粒
CN109562355A (zh) 2016-08-18 2019-04-02 芝加哥大学 用于高效有机转化的金属氧化物负载的地球丰富的金属催化剂
WO2019028250A1 (en) 2017-08-02 2019-02-07 The University Of Chicago NOMOGENEOUS ORGANOMETALLIC ORGANOMETRIC ORGANOMETRIC LAYERS FOR X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, RODIODYNAMIC THERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF
US20190314324A1 (en) 2018-04-13 2019-10-17 The University Of Chicago Combination of micheliolide derivatives or nanoparticles with ionizing radiation and checkpoint inhibitors for cancer therapy
US12042788B2 (en) 2019-08-21 2024-07-23 The University Of Chicago Strongly Lewis acidic metal-organic frameworks for continuous flow catalysis
WO2021237209A1 (en) 2020-05-22 2021-11-25 The University Of Chicago Metal-organic frameworks deliver small molecules and biomacromolecules for cancer immunotherapy

Similar Documents

Publication Publication Date Title
JP2019523757A5 (enExample)
Kaboudin et al. Hydroxy-and amino-phosphonates and-bisphosphonates: synthetic methods and their biological applications
USRE48510E1 (en) Phosphorus functional antimicrobial coatings for metal surfaces
JP6049712B2 (ja) 抗癌治療及び画像化並びに骨障害治療のための金属ビスホスホネートナノ粒子
EP3158867B1 (en) A method for increasing the aqueous solubility of a bisphosphonic acid or a bisphosphonate
JP2006506365A5 (enExample)
JP2016536318A5 (enExample)
US9226897B2 (en) Self-assembling nanoparticles for the release of bisphosphonates in the treatment of human cancers
JP2013523751A5 (enExample)
Tusek–Bozic Aminophosphonate metal complexes of biomedical potential
JP2019512478A5 (enExample)
JP2012500197A5 (enExample)
JP2010535180A5 (enExample)
JP2019511491A5 (enExample)
RU2003133773A (ru) Фармацевтическое применение бисфосфонатов
UA125655C2 (uk) Терапевтичні дендримери
JP2009522369A5 (enExample)
JP2014527969A5 (enExample)
JP2018530582A5 (enExample)
JP2006500401A5 (enExample)
JP2006525368A5 (enExample)
RU2004105144A (ru) Комбинации, включающие эпотилоны, и их фармацевтическое применение
Troev et al. New efficient method of oxidation of poly (alkylene H-phosphonate) s: a promising route to novel co-polyphosphoesters
US20090074833A1 (en) Bridged polycyclic compound based compositions for controlling bone resorption
JP2018530623A5 (enExample)